Acquired Enamel Pellicle Engineered Peptides: Effects on Hydroxyapatite Crystal Growth

Area of Science:

• Biochemistry
• Biomineralization
• Dental Research

Background:

• Naturally occurring pellicle peptides play a role in regulating hydroxyapatite crystal growth.
• Understanding these mechanisms is crucial for enamel remineralization and preventing dental calculus.

Purpose of the Study:

• To investigate if duplicating or hybridizing functional domains of pellicle peptides enhances their inhibitory effect on hydroxyapatite crystal growth.
• To explore a potential protein evolution pathway through peptide engineering.

Main Methods:

• Tested native peptides (Histatin 3, statherin), functional domains (RR14, DR9), and engineered peptides (DR9-DR9, DR9-RR14).
• Assessed hydroxyapatite crystal growth inhibition using a microplate colorimetric assay.
• Determined half-maximal inhibitory concentration (IC50) and analyzed data using ANOVA and Student-Newman-Keuls tests.

Main Results:

• The engineered peptide DR9-DR9 showed a significantly increased inhibitory effect compared to the single DR9 domain (p < 0.05).
• The hybrid peptide DR9-RR14 exhibited an intermediate inhibitory effect between DR9 and DR9-DR9.
• Functional domain multiplication was identified as a potent evolutionary strategy.

Conclusions:

• Duplication of functional domains in engineered peptides can amplify inhibitory effects on hydroxyapatite crystal growth.
• This approach offers insights into natural protein evolution and the development of synthetic peptides.
• Findings support the potential therapeutic application of engineered peptides against dental caries and periodontal disease.